Related Experiment Video
Updated: Mar 17, 2026

Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
Published on: January 3, 2020
Pancreatectomy Outcomes in Pediatric Hyperinsulinism: A Retrospective Single-Center Experience
Seyithan Ozaydin1, Nihal Coskun2, Ipek Yildiz Ozaydin3
1Department of Pediatric Surgery, Istinye University, Liv Hospital Bahcesehir, Istanbul, Turkey.
Insights
Surgery for hyperinsulinism (HI) is crucial for diazoxide-unresponsive cases. Pancreatectomy offers essential treatment, but long-term monitoring for diabetes and hypoglycemia is vital for infant outcomes.
Area of Science:
- Pediatric Surgery
- Endocrinology
- Medical Genetics
Background:
- Hyperinsulinism (HI) is a leading cause of persistent hypoglycemia in infants, potentially causing neurological damage.
- Medical treatments like diazoxide and octreotide are not always effective, especially for severe KATP-channel mutations.
- Surgery is often necessary for patients unresponsive to medical management.
Purpose of the Study:
- To evaluate surgical outcomes in patients with hyperinsulinism at our institution.
- To compare these outcomes with existing literature on surgical management of HI.
- To highlight the importance of a multidisciplinary approach in managing HI.
Main Methods:
- Retrospective review of 14 patients undergoing pancreatectomy for HI (2008-2023).
- Data collected included demographics, genetic findings, imaging, surgical details, complications, and long-term follow-up.
- Analysis of surgical approaches (near-total vs. subtotal pancreatectomy) based on disease presentation (diffuse vs. focal).
Main Results:
- 50% of patients had ABCC8 or KCNJ11 mutations; 78.6% had congenital HI.
- Functional imaging identified focal disease in 3 noncongenital HI patients.
- At 10-year follow-up: 38.4% developed diabetes, 30.8% experienced recurrent hypoglycemia, 30.8% remained euglycemic, and 30.8% had neurodevelopmental delay.
Conclusions:
- Pancreatectomy (near-total and subtotal) is a critical treatment for refractory hyperinsulinism.
- Early genetic testing, advanced imaging, and comprehensive long-term care are essential for optimal patient outcomes.
- Surgical results align with international findings, reinforcing its role in managing severe HI.
Introduction:
Hyperinsulinism (HI) is the most frequent cause of persistent hypoglycemia in neonates and infants. Untreated, this condition can cause permanent neurological impairment. Medical therapies such as diazoxide and octreotide are effective in some cases, but patients with severe KATP-adenosine triphosphate sensitive potassium channel mutations are often unresponsive, requiring surgery. This study evaluates surgical outcomes in HI patients at our institution and compares them with those reported in the contemporary literature.
Methods:
A retrospective review of 14 patients who underwent pancreatectomy for HI between 2008 and 2023 was performed. Collected data included demographics, genetic findings, imaging, surgical approach, operative details, complications, and long-term outcomes.
Results:
Eleven patients (78.6%) had congenital and three (21.4%) noncongenital HI. ABCC8 or KCNJ11 mutations were identified in 50% of cases. The functional imaging localized focal disease in three noncongenital HI patients. Near-total pancreatectomy was performed in cases of diffuse disease, while subtotal resection was performed in cases of focal lesions. One patient died from sepsis. At 10-y mean follow-up, 38.4% developed diabetes mellitus, 30.8% had recurrent hypoglycemia, and 30.8% remained euglycemic. Neurodevelopmental delay occurred in 30.8%.
Conclusions:
Pancreatectomy (near total and subtotal) remains an essential treatment for refractory (diazoxide unresponsive) HI. Our results, aligned with international experience, emphasize the value of early genetic testing, functional and advanced imaging, and multidisciplinary long-term care.
More Related Videos
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

